TG Therapeutics ROI - Return on Investment 2010-2024 | TGTX

TG Therapeutics return on investment for the quarter ending December 31, 2024 was 6.37.

  • TG Therapeutics average return on investment for 2023 was -72.97, a 53.17% decline from 2022.
  • TG Therapeutics average return on investment for 2022 was -155.83, a 40.55% decline from 2021.
  • TG Therapeutics average return on investment for 2021 was -262.14, a 4.67% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.